Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicityCoralie M Backlund, Rebecca L Holden, Kelly D Moynihan, et al.
Science Translational Medicine|November 16, 2018
Cell and fluid sampling microneedle patches for monitoring skin-resident immunityAnasuya Mandal, Archana V Boopathy, Lionel K W Lam, et al.
Cancer Immunology Research|June 20, 2018
Enhancement of Peptide Vaccine Immunogenicity by Increasing Lymphatic Drainage and Boosting Serum StabilityKelly D Moynihan, Rebecca L Holden, Naveen K Mehta, et al.
Science Translational Medicine|January 10, 2024
CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virusFrancesco Andreata, Kelly D Moynihan, Valeria Fumagalli, et al.
Cancer Cell|April 16, 2015
Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2Eric F Zhu, Shuning A Gai, Cary F Opel, et al.
Science Immunology|July 19, 2020
Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 sheddingLawrence P Andrews, Ashwin Somasundaram, Jessica M Moskovitz, et al.
Cancer Discovery|April 2, 2024
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor ImmunityKelly D Moynihan, Manu P Kumar, Hussein Sultan, et al.
Cancer Immunology Research|March 15, 2023
Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I ExpressionZachariah P Tritz, Katayoun Ayasoufi, Delaney M Wolf, et al.
Frontiers in Immunology|July 11, 2022
Identification of Highly Cross-Reactive Mimotopes for a Public T Cell Response in Murine MelanomaBeth E Grace, Coralie M Backlund, Duncan M Morgan, et al.
Nature Medicine|November 8, 2016
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responsesKelly D Moynihan, Cary F Opel, Gregory L Szeto, et al.
Pageof 4